Roadmap for the manufacture of injectable contraceptives in sub-Saharan Africa

The “Roadmap for the manufacture of injectable contraceptives in sub-Saharan Africa” outlines the steps needed to promote the manufacture of medroxyprogesterone acetate intramuscular (MPA-IM), one of the most popular contraceptives used by women in sub-Saharan Africa (SSA). The document summarizes the economic assessment of establishing an MPA-IM manufacturing facility in SSA and provides recommended actions to overcome key challenges in setting up such a facility.